Purification of nucleotide sequences suitable for expression in bacteria
AssigneeThe Regents of the University of California
InventorsHoward M. Goodman, John Shine, Peter Horst
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsHoward M. Goodman, John Shine, Peter Horst
Estimating the term…
A method has been discovered for purifying a specific desired DNA sequence, starting from RNA heterogeneous in length and sequence. The steps of the method include making complementary DNA transcripts of the RNA by means of an enzyme such as reverse transcriptase, subjecting the DNA transcripts to the action of one or more selected restriction endonuclease enzymes, and fractionating the fragments produced by endonuclease action according to their length. By this method it is possible to isolate homogeneous length DNA fragments complementary to RNA sequences present in the original preparation in as low a frequency as two percent. A method is also disclosed for further purifying the homogeneous length fragments and for determining their final purity. Using the disclosed methods, a DNA fragment approximately 550 nucleotides in length coding for a portion of the peptide hormone, human chorionic somatomammotropin, has been purified to greater than 99% purity.
A method for measuring the purity of a specific desired nucleotide sequence in a preparation of DNA fragments of essentially homogeneous length containing said nucleotide sequence, there being at least one restriction site within the specific desired nucleotide sequence, comprising the steps of:
Dependencies are inferred from the claim text.